563 related articles for article (PubMed ID: 15296758)
21. Complementary function of the two catalytic domains of APOBEC3G.
Navarro F; Bollman B; Chen H; König R; Yu Q; Chiles K; Landau NR
Virology; 2005 Mar; 333(2):374-86. PubMed ID: 15721369
[TBL] [Abstract][Full Text] [Related]
22. Human APOBEC3F is another host factor that blocks human immunodeficiency virus type 1 replication.
Zheng YH; Irwin D; Kurosu T; Tokunaga K; Sata T; Peterlin BM
J Virol; 2004 Jun; 78(11):6073-6. PubMed ID: 15141007
[TBL] [Abstract][Full Text] [Related]
23. Antiviral potency of APOBEC proteins does not correlate with cytidine deamination.
Bishop KN; Holmes RK; Malim MH
J Virol; 2006 Sep; 80(17):8450-8. PubMed ID: 16912295
[TBL] [Abstract][Full Text] [Related]
24. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G.
Sawyer SL; Emerman M; Malik HS
PLoS Biol; 2004 Sep; 2(9):E275. PubMed ID: 15269786
[TBL] [Abstract][Full Text] [Related]
25. Degradation of the cancer genomic DNA deaminase APOBEC3B by SIV Vif.
Land AM; Wang J; Law EK; Aberle R; Kirmaier A; Krupp A; Johnson WE; Harris RS
Oncotarget; 2015 Nov; 6(37):39969-79. PubMed ID: 26544511
[TBL] [Abstract][Full Text] [Related]
26. Cytidine deamination and resistance to retroviral infection: towards a structural understanding of the APOBEC proteins.
Huthoff H; Malim MH
Virology; 2005 Apr; 334(2):147-53. PubMed ID: 15780864
[TBL] [Abstract][Full Text] [Related]
27. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase.
Suspène R; Sommer P; Henry M; Ferris S; Guétard D; Pochet S; Chester A; Navaratnam N; Wain-Hobson S; Vartanian JP
Nucleic Acids Res; 2004; 32(8):2421-9. PubMed ID: 15121899
[TBL] [Abstract][Full Text] [Related]
28. Identification of APOBEC3DE as another antiretroviral factor from the human APOBEC family.
Dang Y; Wang X; Esselman WJ; Zheng YH
J Virol; 2006 Nov; 80(21):10522-33. PubMed ID: 16920826
[TBL] [Abstract][Full Text] [Related]
29. Enhancing the Catalytic Deamination Activity of APOBEC3C Is Insufficient to Inhibit Vif-Deficient HIV-1.
Jaguva Vasudevan AA; Hofmann H; Willbold D; Häussinger D; Koenig BW; Münk C
J Mol Biol; 2017 Apr; 429(8):1171-1191. PubMed ID: 28315663
[TBL] [Abstract][Full Text] [Related]
30. Rapid evolution of primate antiviral enzyme APOBEC3G.
Zhang J; Webb DM
Hum Mol Genet; 2004 Aug; 13(16):1785-91. PubMed ID: 15198990
[TBL] [Abstract][Full Text] [Related]
31. Human APOBEC3B is a potent inhibitor of HIV-1 infectivity and is resistant to HIV-1 Vif.
Doehle BP; Schäfer A; Cullen BR
Virology; 2005 Sep; 339(2):281-8. PubMed ID: 15993456
[TBL] [Abstract][Full Text] [Related]
32. Identification of an APOBEC3G binding site in human immunodeficiency virus type 1 Vif and inhibitors of Vif-APOBEC3G binding.
Mehle A; Wilson H; Zhang C; Brazier AJ; McPike M; Pery E; Gabuzda D
J Virol; 2007 Dec; 81(23):13235-41. PubMed ID: 17898068
[TBL] [Abstract][Full Text] [Related]
33. Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion.
Doehle BP; Schäfer A; Wiegand HL; Bogerd HP; Cullen BR
J Virol; 2005 Jul; 79(13):8201-7. PubMed ID: 15956565
[TBL] [Abstract][Full Text] [Related]
34. Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging.
Zhao W; Akkawi C; Mougel M; Ross SR
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641479
[TBL] [Abstract][Full Text] [Related]
35. Remarkable lethal G-to-A mutations in vif-proficient HIV-1 provirus by individual APOBEC3 proteins in humanized mice.
Sato K; Izumi T; Misawa N; Kobayashi T; Yamashita Y; Ohmichi M; Ito M; Takaori-Kondo A; Koyanagi Y
J Virol; 2010 Sep; 84(18):9546-56. PubMed ID: 20610708
[TBL] [Abstract][Full Text] [Related]
36. A single amino acid substitution in human APOBEC3G antiretroviral enzyme confers resistance to HIV-1 virion infectivity factor-induced depletion.
Xu H; Svarovskaia ES; Barr R; Zhang Y; Khan MA; Strebel K; Pathak VK
Proc Natl Acad Sci U S A; 2004 Apr; 101(15):5652-7. PubMed ID: 15054139
[TBL] [Abstract][Full Text] [Related]
37. Quantifying the antiviral effect of APOBEC3 on HIV-1 infection in humanized mouse model.
Kurusu T; Kim KS; Koizumi Y; Nakaoka S; Ejima K; Misawa N; Koyanagi Y; Sato K; Iwami S
J Theor Biol; 2020 Aug; 498():110295. PubMed ID: 32335137
[TBL] [Abstract][Full Text] [Related]
38. APOBEC-mediated interference with hepadnavirus production.
Rösler C; Köck J; Kann M; Malim MH; Blum HE; Baumert TF; von Weizsäcker F
Hepatology; 2005 Aug; 42(2):301-9. PubMed ID: 16025511
[TBL] [Abstract][Full Text] [Related]
39. Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation.
Pace C; Keller J; Nolan D; James I; Gaudieri S; Moore C; Mallal S
J Virol; 2006 Sep; 80(18):9259-69. PubMed ID: 16940537
[TBL] [Abstract][Full Text] [Related]
40. Human-APOBEC3G-dependent restriction of porcine endogenous retrovirus replication is mediated by cytidine deamination and inhibition of DNA strand transfer during reverse transcription.
Jin SY; Choi HY; Kim HS; Jung YT
Arch Virol; 2018 Jul; 163(7):1907-1914. PubMed ID: 29610985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
